Design. Performance. Interpretation.
Using the best science to identify and overcome ADMET barriers in the development of drugs, biologics and medical devices
Continually developing innovative research tools to accurately predict human outcomes and explain unanticipated ones
Preclinical testing that delivers what the FDA demands
- IND- and NDA-enabling services
- Optimized and validated test systems
- Trustworthy and reproducible data
- Comprehensive support for testing and analysis
- Consultative collaboration
Reliable and quick animal PK data with predefined or custom protocols
- Multiple species and dose routes available
- GLP chronic and sub-chronic tox studies
- Complementary dose vehicle development and bioanalysis
State-of-the-art, cutting edge science for understanding drug transporters
- Providing clarity with superior cell lines
- The most definitive assay systems in the industry
- In vitro studies to enable waivers of clinical drug interaction studies
- A decade of experience submitting in vitro,
cell-based permeability data to the FDA
The New Blog
Absorb This!
Explore featured content related to the field of pharmacology, pharmacokinetics, drug-drug interactions, and the pharmaceutical industry.
PK, PD, and TB
Posted by Dr. Chris Bode January 16, 2012
How CROs Support Innovation
Posted by Dr. Stacy Pritt December 7, 2011
Notes From DDI-2011 Conference (Seattle, June 2011)
Posted by Dr. Chris Bode August 11, 2011
Follow us on Twitter @Absorb_This
Recent News
| Absorption Systems Upgrades Ocular Testing Facility Absorption Systems Expands In Vivo Drug Testing Capabilities | |
| Absorption Systems Collaboration Aims to Improve In Vitro Prediction of Pharmacokinetics |
Literature
| In Vitro Drug Safety: The Safety Suite A comprehensive package of in vitro drug-drug interaction and other safety-related tests | |
| CellPort Portfolio of Services |




